MTOR and benign neoplasm: Loss-of-function mutations in one of two tumor suppressor genes, TSC1 and TSC2, lead to the overactivation of the mechanistic target of rapamycin (mTOR) pathway, dysregulation of cell proliferation, and the formation of benign tumors in multiple organ systems, including the brain [3, 4].